Bharat Biotech’s nasal COVID-19 vaccine iNCOVACC, has been approved by the center on Tuesday and at Rs 800 the vaccine will be available in private hospitals and government hospitals, it will be available for Rs 325. In the fourth week of January, the vaccine iNCOVACC will be rolled out. As a heterologous booster dose, people can take this vaccine even if they have taken Covishield and Covaxin. However, for above 18 years iNCOVACC will be given and has been approved by the Government of India.
Kenya sends more officers to Haiti, reinforcing efforts to curb gang violence that has displaced…
Yoon Suk Yeol's detention was extended due to fears of evidence destruction in a martial…
The new underground missile base, capable of launching cruise missiles from advanced speedboats, underscores Iran's…
Iranian state media reports the judges were shot by an assailant who later took his…
In Chihuahua, migrants set mattresses ablaze in response to a raid aimed at clearing the…
Kennedy's petition to halt vaccine approval in 2021 sparked controversy, advocating against mRNA vaccines and…